Advertisement

Cancer Causes & Control

, Volume 9, Issue 3, pp 269–275 | Cite as

Risk Factors for Male Breast Cancer (United States)

  • Ann W. Hsing
  • Joseph K. McLaughlin
  • Pierluigi Cocco
  • Harvey T. Co Chien
  • Joseph F. FraumeniJr.
Article

Abstract

Objectives: The etiology of male breast cancer is obscure, although an excess risk has been associated with Klinefelter syndrome, testicular disorders, benign breast disease including gynecomastia, use of exogenous estrogens, radiation, and a family history of male or female breast cancer. We conducted a case-control study to investigate risk factors further for breast cancer in men.

Methods: Based on data from the 1986 National (United States) Mortality Followback Survey (NMFS) of almost 20,000 deceased adults (age 25 years or over), we compared information obtained from next-of-kin interviews of 178 men who died of breast cancer with that of 512 male controls who died of other causes. Information was obtained on selected demographic and other factors, including diet, exercise, occupation, height and weight, and use of tobacco and alcohol.

Results: Increased risks were found for men who were described by their next-of-kin as very overweight (odds ratio [OR] = 2.3, 95 percent confidence interval [CI] = 1.1-5.0). The risks associated with the three upper quartiles of body mass index (BMI) (wt/ht2) were 1.3, 1.6, and 2.3, respectively, with a significant dose-response relationship (P < 0.01). An excess risk was also associated with limited exercise (OR = 1.3, CI = 0.8-2.0). Consumption of red meat was associated with an increased risk, and consumption of fruits and vegetables with a decreased risk, although the trends were not significant. No association was found for tobacco or alcohol use, but an excess risk was associated with higher levels of socioeconomic status (SES) (OR = 1.8, CI = 1.1-3.0).

Conclusions: Our study suggests that obesity increases the risk of male breast cancer, possibly through hormonal mechanisms, while dietary factors, physical activity, and SES indicators also deserve further investigation. Cancer Causes andd Control 1998, 269-275

Alcohol diet male breast cancer obesity tobacco United States 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997; 47: 5–27.Google Scholar
  2. 2.
    Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlary J, Powell J. Cancer Incidence in Five Continents, Vol VI, Lyon, France: International Agency for Research on Cancer, 1992; IARC Sci. Pub. No. 120Google Scholar
  3. 3.
    Donegan WL. Cancer of the breast in men. CA Cancer J Clin 1991; 41: 339–54.Google Scholar
  4. 4.
    Thomas DB. Breast cancer in men. Epidemiol Rev 1993; 15: 220–31.Google Scholar
  5. 5.
    Narod SA, Ford P, Devilee P, et al. An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. Am J Hum Genet 1995; 56: 254–64.Google Scholar
  6. 6.
    Stratton MR, Ford D, Neuhasen S, et al. Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nat Genet 1994; 7: 103–7.Google Scholar
  7. 7.
    Scheike O, Visfeldt J, Petersen B. Male breast cancer. Breast carcinoma in association with Klinefelter syndrome. Acta Pathol Microbiol Scand 1973; 81: 352–8.Google Scholar
  8. 8.
    Harnden DG, Maclean N, Langlands AO. Carcinoma of the breast and Klinefelter's syndrome. J Med Genet 1971; 8: 460–1.Google Scholar
  9. 9.
    D'Avanzo B, La Vecchia C. Risk factors for male breast cancer. Br J Cancer 1995; 71: 1359–462.Google Scholar
  10. 10.
    Sasco AJ, Cowenfels AB, Pasker-de Jong P. Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 1993; 53: 538–49.Google Scholar
  11. 11.
    Thomas D, Jimenez LM, McTiernan A, et al. Breast cancer in men: Risk factors with hormonal implications. Am J Epidemiol 1992; 135: 734–48.Google Scholar
  12. 12.
    Rosenblatt KA, Thomas DB, McTiernan A, et al. Breast cancer in men: aspects of familial aggregation. J Natl Cancer Inst 1991; 83: 849–54.Google Scholar
  13. 13.
    Lenfant-Pejovic M, Milka-Cabanne N, Bouchardy C, Auquier A. Risk factors for male breast cancer: a Franco-Swiss case-control study. Int J Cancer 1990; 45: 662–5.Google Scholar
  14. 14.
    Rose DP. Endocrine epidemiology of male breast cancer. Anticancer Res 1988; 8: 845–50.Google Scholar
  15. 15.
    Casagrande JT, Hanisch R, Pike MC, Ross RK, Brown JB, Henderson BE. A case-control study of male breast cancer. Cancer Res 1988; 48: 1326–30.Google Scholar
  16. 16.
    Olsson H, Ranstam J. Head trauma and exposure to prolactin-elevating drugs as risk factors for male breast cancer. J Natl Cancer Inst 1988; 80: 679–83.Google Scholar
  17. 17.
    Mabuchi K, Bross ID, Kessler II. Risk factors for male breast cancer. J Natl Cancer Inst 1985; 74: 371–5.Google Scholar
  18. 18.
    Schottenfeld D, Lilienfeld AM. Some epidemiological features of breast cancer among males. J Chronic Dis 1973; 16: 71–81.Google Scholar
  19. 19.
    Thomas DB, Rosenblatt K, Jimenez LM, et al. Ionizing radiation and breast cancer in men (United States). Cancer Causes Control 1994; 5: 9–14.Google Scholar
  20. 20.
    Rosenbaum PF, Vena JE, Zielenzy MA, Michalek AM. Occupational exposures associated with male breast cancer. Am J Epidemiol 1994; 139: 30–6.Google Scholar
  21. 21.
    Stevens RG, Davis S, Thomas DB, Anderson LE, Wilson BW. Electric power, pineal function, and the risk of breast cancer. FASEB J 1992; 6: 853–60.Google Scholar
  22. 22.
    Demers PA, Thomas DV, Rosenblatt KA, et al. Occupational exposure to electromagnetic fields and breast cancer in men. Am J Epidemiol 1991; 134: 340–7.Google Scholar
  23. 23.
    Matanoski GM, Breysse PN, Elliott EA. Electromagnetic field exposure and male breast cancer. Lancet 1991; 337: 737.Google Scholar
  24. 24.
    Heath CW. Electromagnetic field exposure and cancer: A review of epidemiologic evidence. CA Cancer J Clin 1996; 46: 29–44.Google Scholar
  25. 25.
    Seeman A, Poe G, McLaughlin JK. Design of the 1986 National Mortality Followback Survey: consideration on collection data on decedents. Public Health Rep 1989; 104: 183–8.Google Scholar
  26. 26.
    Hsing AW, Hoover RN, McLaughlin JK, et al. Oral contraceptives and primary liver cancer among young women. Cancer Causes Control 1992; 3: 43–8.Google Scholar
  27. 27.
    Hsing AW, Nam JM, Co Chien H, McLaughlin JK, Fraumeni JF Jr. Risk factors for adrenal cancer: an exploratory study. Int J Cancer 1996; 65: 432–6.Google Scholar
  28. 28.
    World Health Organization. International Classification of Diseases, Ninth Revision. Geneva, Switzerland: WHO, 1977.Google Scholar
  29. 29.
    Breslow NE, Day NE. Statistical Methods in Cancer Research, Volume 1, The Analysis of Case-control Studies. International Agency for Research on Cancer, Lyon, France: 1980; IARC Sci. Pub. No. 32.Google Scholar
  30. 30.
    Kelsey JL. Breast cancer epidemiology: Epidemiol Rev 1993; 15: 256–63.Google Scholar
  31. 31.
    Kirschner MA, Schneider G, Ertel HH, et al. Obesity, androgens, estrogens, and cancer risk. Cancer Res 1982; 42 (Suppl): 32815–44.Google Scholar
  32. 32.
    Schneider J, Bradlow HL, Strain G, Levin J, Anderson C, Fishman J. Effects of obesity on estradiol metabolism. Decreased formation of nonuterotropic metabolites. J Clin Endocrinol Metab 1983; 56: 973–8.Google Scholar
  33. 33.
    Ota DM, Jones LA, Jackson GL, Jackson PM, Kemp K, Bauman D. Obesity, non-protein-bound estradiol levels, and distribution of estradiol in the sera of breast cancer patients. Cancer 1986; 57: 558–62.Google Scholar
  34. 34.
    Dao TL, Morreal C, Nemoto T. Urinary estrogen excretion in men with breast cancer. N Engl J Med 1973; 289: 138–40.Google Scholar
  35. 35.
    Nirmul D, Pegoraro RJ, Jiala I, Naidoo C, Joubert SM. The sex hormone profile of male patients with breast cancer. Br J Cancer 1982; 48: 423–7.Google Scholar
  36. 36.
    Calabresi E, DeGuili G, Becciolini A, et al. Plasma estrogens and androgens in male breast cancer. J Steroid Biochem 1976; 7: 605–9.Google Scholar
  37. 37.
    McLaughlin JK, Malker HS, Blot WJ, Weiner JA, Ericsson JLE, Fraumeni JF Jr. Occupational risks for male breast cancer in Sweden. Br J Ind Med 1988; 45: 275–6.Google Scholar
  38. 38.
    Nuttall FQ. Gynecomastia as a physical finding in normal men. J Clin Endocrinol Metab 1979; 48: 338.Google Scholar
  39. 39.
    Longnecker MP, Newcomb PA, Mittendorf R, Greenberg R. Risk of breast cancer in relation to lifetime alcohol consumption. J Natl Cancer Inst 1995; 87: 923–9.Google Scholar
  40. 40.
    McLaughlin JK, Blot WJ, Mehl ES, Mandel JS. Problems in the use of dead controls in case-control studies: I. General results. Am J Epidemiol 1985; 121: 131–9.Google Scholar
  41. 41.
    McLaughlin JK, Blot WJ, Mehl ES, Mandel JS. Problems in the use of dead controls in case-control studies: II. Effect of excluding certain causes of death. Am J Epidemiol 1985; 122: 485–94.Google Scholar
  42. 42.
    Department of Health and Human Services. Reducing the health consequences of smoking: 25 years of progress. A report of the Surgeon General. Atlanta, GA (USA): Department of Health and Human Services, 1989; DHHS Publ. No. (CDC) 89-8411.Google Scholar
  43. 43.
    Smith AH, Pearce N, Cellas PW. Cancer case-control studies with other cancers as controls. Int J Epidemiol 1988; 17: 298–306.Google Scholar

Copyright information

© Lippincott-Raven Publishers 1998

Authors and Affiliations

  • Ann W. Hsing
    • 1
  • Joseph K. McLaughlin
    • 2
  • Pierluigi Cocco
    • 1
  • Harvey T. Co Chien
    • 3
  • Joseph F. FraumeniJr.
    • 1
  1. 1.Division of Cancer Epidemiology and GeneticsNational Cancer InstituteBethesdaUSA
  2. 2.International Epidemiology InstituteRockvilleUSA
  3. 3.Westat Inc.RockvilleUSA

Personalised recommendations